![]() |
Volumn 141, Issue 2, 1999, Pages 274-278
|
Topical maxacalcitol for the treatment of psoriasis vulgaris: A placebo- controlled, double-blind, dose-finding study with active comparator
|
Author keywords
1 ; 25 dihydroxy 22 oxacalcitriol (maxacalcitol); Calcipotriol; Clinical trial; Ointment; Psoriasis vulgaris
|
Indexed keywords
22 OXACALCITRIOL;
CALCIPOTRIOL;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE CALCULATION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG DOSAGE FORM;
DRUG EFFICACY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PSORIASIS VULGARIS;
RANDOMIZED CONTROLLED TRIAL;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CALCITRIOL;
DERMATOLOGIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ERUPTIONS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
OINTMENTS;
PSORIASIS;
TREATMENT OUTCOME;
|
EID: 0032811171
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.1999.02975.x Document Type: Article |
Times cited : (96)
|
References (4)
|